Press Releases Ketamine - PharmaTher Holdings Ltd. Ketamine

OTCQB: PHRRF | CSE: PHRM

HOME
COMPANY
- Management
- Board Of Directors
PRODUCTS
INVESTORS
NEWS
CONTACT

HOME
COMPANY
- Management
- Board Of Directors
PRODUCTS
INVESTORS
NEWS
CONTACT

Press Releases

11/30/2021

PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

11/24/2021

PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

11/11/2021

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

11/3/2021

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

11/1/2021

PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics

Archives

October 2025
August 2025
July 2025
June 2025
May 2025
March 2025
February 2025
January 2025
November 2024
October 2024
September 2024
August 2024
May 2024
April 2024
February 2024
January 2024
September 2023
July 2023
June 2023
May 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020

Categories

"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."

© COPYRIGHT 2025. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.